drugset / Trial / NCT00283478
Iscar for Second Line Treatment of Advanced Non-Small Cell Lung Cancer
RandomizedParallel-groupOpen-labelTreatment
Summary
To determine if Iscar Quercus improves immune function and quality of life among patients with stage IV non-small cell lung cancer.
Timeline
- Start
- 2004-05
- Primary completion
- —
- Completion
- 2007-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Iscar Quercus | Unknown | — | — |
| Background | Gemcitabine | Small molecule | — | — |